Dr Anju Goyal

Prof. Dr Anju Goyal

Chitkara University Punjab
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SKSAPNA KUMARI
SAPNA KUMARI
DGDr Anju Goyal
Dr Anju Goyal
EGEda Sönmez Gürer
Eda Sönmez Gürer
EYEvren ALGIN YAPAR
Evren ALGIN YAPAR
MGMadhukar Garg
Madhukar Garg
RSRakesh K Sindhu
Rakesh K Sindhu
Plant-based medicines have received a lot of attention in recent years. Such medicines have been employed to treat medical conditions since ancient times, and in those times only the observed symptoms were used to determine dose accuracy, dose efficacy, and therapy. Rather than novel formulations, the current research work on plant-based medicines has mostly concentrated on medicinal active phytoconstituents. In the past recent decades, however, researchers have made significant progress in developing “new drug delivery systems” (NDDS) to enhance therapeutic efficacy and reduce unwanted effects of bioactive compounds. Nanocapsules, polymer micelles, liposomes, nanogels, phytosomes, nano-emulsions, transferosomes, microspheres, ethosomes, injectable hydrogels, polymeric nanoparticles, dendrimers, and other innovative therapeutic formulations have all been created using bioactive compounds and plant extracts. The novel formulations can improve solubility, therapeutic efficacy, bioavailability, stability, tissue distribution, protection from physical and chemical damage, and prolonged and targeted administration, to name a few. The current study summarizes existing research and the development of new formulations, with a focus on herbal bioactive components.

27 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
DGDr Anju Goyal
Dr Anju Goyal
ASAditya Sharma
Aditya Sharma
JKJasanpreet Kaur
Jasanpreet Kaur
SKSAPNA KUMARI
SAPNA KUMARI
MGMadhukar Garg
Madhukar Garg
Mohamed Abdel-DaimMohamed Abdel-Daim
Mohamed Abdel-Daim
Cosmetic-containing herbals are a cosmetic that has or is claimed to have medicinal properties, with bioactive ingredients purported to have medical benefits. There are no legal requirements to prove that these products live up to their claims. The name is a combination of “cosmetics” and “pharmaceuticals”. “Nutricosmetics” are related dietary supplements or food or beverage products with additives that are marketed as having medical benefits that affect appearance. Cosmetic-containing herbals are topical cosmetic–pharmaceutical hybrids intended to enhance the health and beauty of the skin. Cosmetic-containing herbals improve appearance by delivering essential nutrients to the skin. Several herbal products, such as cosmetic-containing herbals, are available. The present review highlights the use of natural products in cosmetic-containing herbals, as natural products have many curative effects as well as healing effects on skin and hair growth with minimal to no side effects. A brief description is given on such plants, their used parts, active ingredients, and the therapeutic properties associated with them. Mainly, the utilization of phytoconstituents as cosmetic-containing herbals in the care of skin and hair, such as dryness of skin, acne, eczema, inflammation of the skin, aging, hair growth, and dandruff, along with natural ingredients, such as for hair colorant, are explained in detail in the present review.

11 September 2020 in Anti-Infective Agents
Verified
Journal Article
Closed access
PDF file
HKHarish Kumar
Harish Kumar
KBKushal Kumar Bansal
Kushal Kumar Bansal
DGDr Anju Goyal
Dr Anju Goyal
Background: Due to newly emerging microbial infections and the development of resistance against cutting-edge therapeutics, innovative and robust medicinal agents are required. Small ring heterocycles, such as pyrazole and its derivatives have been acknowledged to possess myriad biological properties and the presence of pyrazole in clinics like celecoxib, phenylbutazone (anti-inflammatory), CDPPB (antipsychotic), rimonabant (anti-obesity), antipyrine, difenamizole (analgesic), fipronil (broad-spectrum insecticidal), betazole (H2-receptor agonist) and fezolamide (antidepressant) drugs has proven the pharmacological perspective of pyrazole nucleus. Objectives: The current review paper aimed at a recent update made on novel methodologies adopted in the synthesis of pyrazole derivatives with the emphasis on antibacterial (DNA gyrase inhibition) and antifungal activities. Methods: Pyrazole is one of the major tools to be investigated in drug design and discovery. Many studies have been reported by researchers that have claimed the significant biological potential of these derivatives. However, numerous studies on pyrazoles compounds shown to exhibit potential antifungal and antibacterial activities, the focus has also been made on DNA gyrase inhibition. Additionally, some important patents granted to this heterocyclic nucleus related to antimicrobial potential are also addressed appropriately. Results: DNA gyrase is a promising biotarget yet to be explored against a number of medicinal agents. The present work provides valuable insight into synthetic methods and antibacterials/antifungal significance of pyrazoles in general as well as new inhibitors of DNA gyrase in particular. Conclusion: The manuscript constitutes a valuable reference which advocates candidature of pyrazoles as a potential therapeutic alternative as antibacterial and antifungal agent.

13 January 2023 in Crystals
Verified
Journal Article
Open access
PDF file
SKSAPNA KUMARI
SAPNA KUMARI
DGDr Anju Goyal
Dr Anju Goyal
MGMadhukar Garg
Madhukar Garg
AAAngela Antonescu
Angela Antonescu
RSRakesh K Sindhu
Rakesh K Sindhu
Astaxanthin is a xanthophyll carotenoid, well known for its potent anti-inflammatory and antioxidant properties, owing to its unsaturated molecular structure. Aquatic plants and animals contain the hydrophobic carotenoid astaxanthin, which is thought to possess a number of advantageous biological traits. However, due to its weak bioavailability and low water solubility, its use as a nutraceutical in food is currently restricted. Cubosomal encapsulation has been considered an effective alternative for improving the bioavailability and solubility of hydrophobic bioactives. The current paper aimed to conquer these issues by encapsulating astaxanthin in lyotropic liquid crystal nano-formulations prepared via the fabrication method. The physicochemical properties of astaxanthin-loaded cubosomes (AST-LC) have also been analyzed, in order to know the morphology of the prepared formulations and their bioavailability in the biological system. The formulation has been tested for particle size, thermal behavior, zeta potential, crystallinity, encapsulation efficiency, and drug-polymer interactions. The observed experimental results showed the particle size and zeta potential of astaxanthin-loaded cubosomes (AST-LC) as 199 ± 0.23 nm −27.4 ± 4.67 mV, with a small polydispersity index (0.283 ± 1.01). The cubic structure and nano-range size of the ideal formulation were verified by a field emission scanning electron microscope (FESEM) and (HRTEM) high-resolution transmission electron microscopic examination. The formulation exhibits a higher encapsulation efficiency with good yield. Results from X-ray diffraction and diffraction scanning calorimetry demonstrated an amorphous state of astaxanthin incorporated into the formulation. Fourier transform infrared spectroscopy (FTIR) analysis of AST-LC showed the absence of astaxanthin main peaks, indicating its complete encapsulation inside the formulation. The drug–excipient interaction was carried out with diffraction scanning calorimetry DSC and FTIR, resulting in no interaction between them. These results offered important details about increasing astaxanthin bioavailability by incorporating it into cubosomes. Furthermore, the astaxanthin loaded into cubosomes has been evaluated for antioxidant potency, compared with astaxanthin extract using 2,2-diphenylpicrylhydrazylassay (DPPH assay).

24 March 2023 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
SKSapna Kumari
Sapna Kumari
DGDr Anju Goyal
Dr Anju Goyal
MGMadhukar Garg
Madhukar Garg

16 March 2011 in Communications in Statistics - Simulation and Computation
Verified
Journal Article
Closed access
VMVishal Maurya
Vishal Maurya
AGAnju Goyal
Anju Goyal
AGAmar Nath Gill
Amar Nath Gill
In this article, the design-oriented two-stage and data analysis one-stage multiple comparison procedures for comparing several two-parameter exponential populations with more than one control population under heteroscedasticity are proposed. One-sided and two-sided simultaneous confidence intervals are also given. Upper limits of critical values are obtained using the recent techniques given in Lam ( 1987 Lam , K. ( 1987 ). Subset Selection of Normal Populations under Heteroscedasticity . Proceedings of the Second International Advanced Seminar/Workshop on Inference Procedures Associated with Statistical Ranking and Selection , Sydney , Australia , August . [Google Scholar] , 1988 Lam , K. ( 1988 ). An improved two-stage selection procedure . Communications in Statistics—Simulation and Computation 17 ( 3 ): 995 – 1006 . [Taylor & Francis Online], [Web of Science ®] [Google Scholar] ). These approximate critical values are shown to have better results than the approximate critical values using the Bonferroni inequality developed in this article. The multiple comparisons of test treatments with the best control are also developed. Finally, the application of the proposed procedures is illustrated with an example.